The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2024, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $14.13 B in revenue, representing 4.57% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.31 B in revenue, representing 3.66% of its total revenue.
- Prescription Technology Solutions generated $4.77 B in revenue, representing 1.54% of its total revenue.
- U.S. Pharmaceutical Segment generated $278.74 B in revenue, representing 90.22% of its total revenue.
The
biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 90.22% of its total revenue.
The
smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.54% of its total revenue.
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2025, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $14.72 B in revenue, representing 4.1% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.39 B in revenue, representing 3.17% of its total revenue.
- Prescription Technology Solutions generated $5.22 B in revenue, representing 1.45% of its total revenue.
- U.S. Pharmaceutical Segment generated $327.72 B in revenue, representing 91.28% of its total revenue.
The
biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 91.28% of its total revenue.
The
smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.45% of its total revenue.
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2026, McKesson Corporation's revenue by segment is as follows:
- Medical-Surgical Solutions Segment generated $11.51 B in revenue, representing 2.85% of its total revenue.
- North American Pharmaceutical Segment generated $336.65 B in revenue, representing 83.45% of its total revenue.
- Oncology And Multispecialty Segment generated $48.42 B in revenue, representing 12% of its total revenue.
- Prescription Technology Solutions Segment generated $5.81 B in revenue, representing 1.44% of its total revenue.
- Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment generated $1.04 B in revenue, representing 0.26% of its total revenue.
The
biggest segment for McKesson Corporation is the North American Pharmaceutical Segment, which represents 83.45% of its total revenue.
The
smallest segment for McKesson Corporation is the Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment, which represents 0.26% of its total revenue.
Submit Feedback
